A recent study suggests that patients who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy can put back on lost weight much more quickly than those who end traditional diet and exercise plans.
Findings released in a prominent medical journal shows that while overweight people often shed a large proportion of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month after stopping.
"People purchasing such drugs must be aware of the risk of fast weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.
Such speed of regain means a reversion to original weight in about a year and a half.
Comparing Treatments
The study, which looked at 37 of studies involving thousands of patients, compared the effects of the injectable medications with older methods.
The team emphasize that people who shed pounds through lifestyle changes alone usually experience a more gradual weight regain—approximately 0.1 kg a month—after stopping.
The Reason for the Quick Regain
Experts believe the mode of action of the jabs accounts for the heightened regain.
The injections mimic a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Long-term administration of GLP-1 levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its endogenous GLP-1, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.
"Discontinuation of this medication means hunger is uncontrolled, making binge eating a significant risk."
A Lifelong Issue?
Medical guidelines recommend the injections for individuals with weight-linked medical conditions, alongside recommended lifestyle changes.
Many experts contend that, considering the likelihood of weight regain, the treatment should be considered ongoing.
This opinion is reinforced by drug manufacturers, who note that the findings "highlight the chronic character of excess weight," comparing it to managing conditions like diabetes.
User Testimonies
Users who have discontinued the medication report a powerful resurgence of cravings.
"It was like a switch that goes on and I was suddenly extremely hungry," recalled an individual.
This difficulty is compounded if users have not established lasting lifestyle or habit modifications during treatment.
Growing Adoption
Figures show that a significant number of adults in the UK have tried these injections in the last 12 months, with demand being substantial.
- Adoption is more common among females compared to males.
- The middle-aged age group shows the highest usage rates.
- Many access the medications through private prescriptions rather than the NHS.
Ultimately, clinicians caution that while GLP-1 drugs are potent agents for weight loss, they are not a permanent solution and lasting health benefits hinges on ongoing lifestyle management.